no statement of use filed
on 12 Dec 2022
Last Applicant/ Owned by
430 E. 29th Street, 14th loor
New York
NY
10016
Serial Number
90182586 filed on 15th Sep 2020
Registration Number
N/A
Correspondent Address
Marilyn . Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical information services, namely, providing medical information to physicians, health care professionals, and patients on the topic of cancer Printed matter, namely, magazines, books, booklets, brochures, pamphlets, newsletters and catalogs in the field of pharmaceutical preparations for the treatment of cancer Pharmaceutical preparations for human use for the treatment and prevention of obeRead More
Medical information services, namely, providing medical information to physicians, health care professionals, and patients on the topic of cancer
Printed matter, namely, magazines, books, booklets, brochures, pamphlets, newsletters and catalogs in the field of pharmaceutical preparations for the treatment of cancer
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for use in disease testing
No 90182586
No Service Mark
No 00156563-US
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 12th Dec 2022 | ABANONMENT - NO USE STATEMENT ILE |
| 12th Dec 2022 | ABANONMENT NOTICE E-MAILE - NO USE STATEMENT ILE |
| 10th May 2022 | NOTICE O APPROVAL O EXTENSION REQUEST E-MAILE |
| 06th May 2022 | SOU TEAS EXTENSION RECEIVE |
| 06th May 2022 | SOU EXTENSION 1 ILE |
| 06th May 2022 | SOU EXTENSION 1 GRANTE |
| 09th Nov 2021 | NOA E-MAILE - SOU REQUIRE ROM APPLICANT |
| 14th Sep 2021 | PUBLISHE OR OPPOSITION |
| 14th Sep 2021 | OICIAL GAZETTE PUBLICATION CONIRMATION E-MAILE |
| 26th Aug 2021 | NOTIICATION O NOTICE O PUBLICATION E-MAILE |
